Table 2

Diagnostic tests for PCD with specification of rationale, requirements for infrastructure, strengths and limitations, and contribution to the final diagnosis

InvestigationRationaleInfrastructure requiredStrengths and limitationsContribution to final decision
nNOVery low in most PCD patientsChemiluminescence analyser (portable analysers are acceptable for screening)
Staff trained to take measurements and interpret results according to ATS/ERS standards [21]
Sensitivity and specificity good but not 100%
International measurements standards
“Gold standard” (velum closure) impossible in young children
Tidal breathing method as alternative in young children but healthy infants have low nNO
Screening test for patients with clinical symptoms
Contributes to diagnostic decision but in isolation does not rule in or rule out PCD
HSVA
 CBFCBF can be slow or fast in some patients with PCDHigh-speed video (capable of 250–500 fps) attached to high-resolution microscope
Observer with extensive experience of normal and abnormal
Neither sensitive nor specific
No standards for measurement or reporting
Should only be used in combination with CBP
 CBPAbnormal ciliary beating is a feature of PCDHigh-speed video (capable of 250–500 fps) attached to high-resolution microscope
Observer with extensive experience of normal and abnormal
Accuracy improved by reanalysis following cell culture (to mitigate secondary defects)
Sensitivity excellent but specificity can be a problem due to secondary defects (e.g. infections)
No standards for measurement or reporting
Contributes to diagnostic decision but in isolation does not rule in or rule out PCD
TEMAbnormal ciliary ultrastructure is a feature of some phenotypesElectron microscope
Observer with extensive experience of normal and abnormal
Analysis of sufficient cilia (e.g. 100) in transverse section from different healthy cells
Diagnostic if “hallmark” abnormalities are found
Sensitivity limited, as 15–20% of patients have normal ultrastructure; not useful in isolation
No standards for measurement or reporting
Confirms the diagnosis if “hallmark” abnormalities are present
Does not rule out PCD if normal
GenotypingPCD is a genetic disorderSpecialist genetic services with knowledge of the complexities of PCD
Parental segregation for new mutations
Diagnostic if pathogenic biallelic mutations found
No studies have investigated its role as a diagnostic test
National and international standards for clinical genetic reports
Confirms diagnosis if pathogenic biallelic mutations are identified
Known mutations are identified in 65% of patients with PCD
Does not rule out PCD
IF staining of proteinsSpecific proteins are missing from ciliaStandard pathology IF labelling
Observer with extensive experience of normal and abnormal
Faster and cheaper to assess ciliary ultrastructure than TEM
Antibodies not commercially available for all ciliary proteins
No standards for measurement or reporting
Until Task Force report, no publications on role as a diagnostic test
A recent single-centre study suggests usefulness

CBF: ciliary beat frequency; CBP: ciliary beat pattern; ATS: American Thoracic Society; fps: frames per second.